Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?
source: pixabay.com

Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?

According to a story from curetoday.com, Dr. Tara Seery is an investigator in a phase 3 trial called PROOF, and she has just one goal: finding better treatments for cholangiocarcinoma,…

Continue Reading Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?
Inventiva Will Present Findings from Maroteaux-Lamy Syndrome Trial at Upcoming Conference
source: pixabay.com

Inventiva Will Present Findings from Maroteaux-Lamy Syndrome Trial at Upcoming Conference

According to a story from globenewswire.com, the biopharmaceutical company Inventiva is scheduled to present the findings from a recent phase IIa clinical trial at the upcoming 16th Annual WorldSymposium™ which is…

Continue Reading Inventiva Will Present Findings from Maroteaux-Lamy Syndrome Trial at Upcoming Conference
Losmapimod Receives Orphan Drug Designation for the Treatment of FSHD
source: pixabay.com

Losmapimod Receives Orphan Drug Designation for the Treatment of FSHD

Losmapimod is an experimental treatment for facioscapulohumeral muscular dystrophy (FSHD), and it recently received the Orphan Drug designation from the FDA. Not only did it receive this designation, but its…

Continue Reading Losmapimod Receives Orphan Drug Designation for the Treatment of FSHD
Chan Zuckerberg Initiative Breaks into Rare Diseases with 30 Grants for Patient Groups
sasint / Pixabay

Chan Zuckerberg Initiative Breaks into Rare Diseases with 30 Grants for Patient Groups

As originally reported in StatNews, Mark Zuckerberg, founder of Facebook, along with his wife, Dr. Priscilla Chan, a former pediatrician and now head of the Chan Zuckerberg Initiative, made an…

Continue Reading Chan Zuckerberg Initiative Breaks into Rare Diseases with 30 Grants for Patient Groups
New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease
source: pixabay.com

New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease

According to a story from Medical Xpress, a new technological approach developed at the University of Texas Health Science Center at Houston will allow doctors to distinguish between Parkinson's disease…

Continue Reading New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease
Close Menu